OXFORD INDUSTRIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data OXFORD INDUSTRIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,023	1,086	1,107	1,123	749	1,142	1,412	1,571	1,517	1,478
Cost of revenue	442	474	470	478	334	436	523	576	562	580
Gross profit	580	613	637	645	415	706	889	996	955	898
Selling, general and administrative	505	541	561	566	493	574	692	757	787	818
Selling and marketing	53	55.2	60	56	50	60	82	105	111	104
Operating expenses								934	855	945
Operating income	89.9	86	90.6	93.7	-124	166	219	81	119	-31.3
Interest expense	3.42	3.11	2.28
Pre-tax income	86.5	82.9	88.3	92.4	-126	165	216	74.9	117	-38.2
Income tax	32	18.2	22	23.9	-30.2	33.2	50	14.2	23.6	-10.3
Income from continuing operations	54.5	64.7	66.3	68.5
Net income	52.5	65.1	66.3	68.5	-95.7	131	166	60.7	93	-27.9
EBITDA	132	128	133	134	-63.9	207	268	145	187	34.6
EPS, basic	3.18	3.92	3.97	4.09	-5.77	7.90	10.42	3.89	5.94	-1.86
EPS, diluted	3.15	3.89	3.94	4.05	-5.77	7.78	10.19	3.82	5.87	-1.86
Shares, basic (weighted)	16.5	16.6	16.7	16.8	16.6	16.6	15.9	15.6	15.7	15
Shares, diluted (weighted)	16.6	16.7	16.8	16.9	16.6	16.9	16.3	15.9	15.8	15
Dividend per share	1.08	1.08	1.36	1.48	1.00	1.63	2.20	2.60	2.68	2.76

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	6.33	6.34	8.33	52.5	66	44.9	8.83	7.6	9.47	8.13
Short-term investments					0	165	0
Receivables	58.3	67.5	69	57.9	30.4	31.6	44	63.4	77.8	73
Inventory	142	127	161	152	124	118	220	160	167	165
Other current assets	24.8	35.4	31.8	25.4	20.4	21.6	38.1	43	38.3	46.1
Total current assets	232	236	270	289	258	400	330	293	293	292
Property, plant and equipment	194	194	193	192	160	152	178	195	273	326
Lease right-of-use assets				287	234	195	241	264	364	380
Goodwill	60	66.7	66.6	66.6	23.9	23.9	120	27.2	27.4	25.6
Intangible assets	175	179	176	175	156	155	284	262	258	189
Other non-current assets	24.3	24.7	22.1	24.3	33.7	30.6	32.2	32.2	54.3	61.8
Total assets	685	700	727	1,033	866	958	1,189	1,098	1,290	1,309
Accounts payable	76.8	68.3	81.6	65.5	71.1	80.8	94.6	85.5	105	105
Accrued liabilities	19.7	29.9	24.2	19.4	18.9	30.3	35	23.7	22.3	28.8
Deferred revenue		10	12	12	13	16	19	20	22	23
Total current liabilities	131	135	142	178	196	226	270	241	248	265
Long-term debt	91.5	45.8	13				119	29.3	31.1	116
Lease liabilities				292	240	199	221	244	359	382
Other non-current liabilities	70	74	75.3	18.6	23.7	21.4	20.1	23.3	28.5	29.9
Total liabilities	309	270	249	505	460	450	632	537	667	794
Total debt	91.5	45.8	13				119	29	31.1	116
Paid-in capital	131	137	143	149	157	163	172	179	191	206
Retained earnings	233	280	324	367	236	331	370	369	420	296
Other comprehensive income	-5.28	-4.07	-5.1	-4.66	-3.66	-3.47	-1.82	-2.74	-3.68	-1.71
Shareholders' equity	376	430	478	529	406	508	556	561	623	515
Total equity	376	430	478	529	406	508	556	561	623	515
Total liabilities and equity	685	700	727	1,033	866	958	1,189	1,098	1,290	1,309
Shares outstanding	16.8	16.8	17	17	17	17	16	16	16	15

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	52.5	65.1	66.3	68.5	-95.7	131	166	60.7	93	-27.9
Depreciation and amortization	42.1	42.4	42.5	40.3	59.9	41.6	49	64.1	67.9	65.9
Stock-based compensation	6.45	6.41	7.33	7.62	7.76	8.19	10.6	14.5	16.7	15.7
Deferred income tax	7.88	1.82	2.93	-1.97	-18.3	4.05	-1.87	-23.9	3.69	-13.6
Change in receivables	7.38	-8.27	-6.02	10.3	28.4	-0.02	-1.97	-15	-7.65	10.8
Change in inventory	4.22	19.5	-36.5	8.19	29.4	5.38	-79	62.5	-8.24	3.19
Change in payables		1.29	5.08	-14.3	17.6	27.6	8.64	-28.1	9.52	15.4
Cash from operations	119	119	96.4	122	83.9	198	126	244	194	120
Capital expenditures	-49.4	-38.7	-37	-37.4	-28.9	-31.9	-46.7	-74.1	-134	-108
Acquisitions	-95	-15.5	-0.35				-264	-12	-7.69	-0.03
Purchases of investments						-165	-70	0	0
Cash from investing	-146	-54.3	-37.4	-37.4	-34.7	-182	-152	-84	-143	-108
Stock issued	1.26	1.38	1.46	1.64	1.38	1.45	1.6	1.91	1.85	1.62
Share buybacks	-1.87	-2.21	-2.35		-18.1	-8.36	-91.7	-20	0	-55.2
Dividends paid	-18.1	-18.2	-23.1	-25.2	-16.8	-27.5	-35.3	-41.7	-43.2	-42.1
Cash from financing	27.4	-64.7	-56.8	-41.3	-35.8	-38.2	-11.5	-161	-48.6	-12.9
Exchange rate effect	0.57	0.41	-0.23	0.93	0.2	0.59	1.63	-0.35	-0.29	0.31
Net change in cash		-0.4	2.22	43.2	13.4	-21.7	-37.7	-0.87	2.16	-1.65
Free cash flow	69.2	79.8	59.3	84.5	54.9	166	78.9	170	59.8	11.3
Interest paid	2.63	2.77	2.11
Income taxes paid	29.9	21	14	17	6	34	56	39		11.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $25.95 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	63.6%	Gross profit / revenue.
Operating margin	-0.1%	Operating income / revenue.
EBITDA margin	4.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-0.6%	Pre-tax income / revenue.
Net margin	-0.5%	Net income / revenue.
FCF margin	3.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	9.4%	Cash from operations / revenue.
Return on equity (ROE)	-1.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-0.5%	Net income / average total assets.
Return on invested capital (ROIC)	-0.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	54.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	5.8%	Capital expenditures / revenue.
D&A / revenue	4.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-2.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	14.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-6.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	0.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	16.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-126.3%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-81.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-49.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-130.0%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-131.7%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-38.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-1.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	7.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-81.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-47.7%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-27.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	3.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	7.9%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	22.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-17.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-2.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-5.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-2.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.17x	Current assets / current liabilities.
Quick ratio	0.30x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.04x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.13x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	5.6%	Total debt / total assets.
Liabilities / assets	56.6%	Total liabilities / total assets.
Net debt	$64.2M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.08x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$41.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	16.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	$353.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.13x	Revenue / average total assets.
Fixed asset turnover	4.38x	Revenue / average property, plant and equipment.
Inventory turnover	3.63x	Cost of revenue / average inventory.
Days inventory	100 days	365 x average inventory / cost of revenue.
Receivables turnover	23.7x	Revenue / average receivables.
Days sales outstanding	15 days	365 x average receivables / revenue.
Days payables	57 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	59 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	62.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.45	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$97.33	Revenue / diluted weighted shares.
FCF per share	$3.46	Free cash flow / diluted weighted shares.
Operating cash flow per share	$9.11	Cash from operations / diluted weighted shares.
Book value per share	$37.44	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$23.42	Tangible book value / shares outstanding.
Cash per share	$0.60	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	81.4%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	0.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$387.5M	Share price x shares outstanding.
Enterprise value	$451.7M	Market cap + total debt - cash - short-term investments.
P/S	0.26x	Market cap / revenue.
P/B	0.69x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.10x	Market cap / tangible book value, when positive.
P/FCF	7.43x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	2.82x	Market cap / cash from operations, when positive.
EV/Sales	0.31x	Enterprise value / revenue.
EV/EBITDA	7.61x	Enterprise value / EBITDA, when both are positive.
EV/FCF	8.67x	Enterprise value / free cash flow, when both are positive.
FCF yield	13.5%	Free cash flow / market cap.
Earnings yield	-1.8%	Net income / market cap (the inverse of P/E).
Dividend yield	10.9%	Dividends paid over the period / market cap.
Shareholder yield	11.0%	(Dividends paid + share buybacks) / market cap.

What was OXFORD INDUSTRIES INC's revenue in fiscal 2025?

OXFORD INDUSTRIES INC reported revenue of $1.48B for fiscal 2025, 2.6% lower than the year before.

Was OXFORD INDUSTRIES INC profitable in fiscal 2025?

No. It reported a net loss of $27.9M.

How much free cash flow did OXFORD INDUSTRIES INC generate in fiscal 2025?

Cash from operations of $119.6M minus capital expenditures of $108.3M left free cash flow of $11.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to OXFORD INDUSTRIES INC